Latest Insider Transactions at Angiodynamics Inc (ANGO)
This section provides a real-time view of insider transactions for Angiodynamics Inc (ANGO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ANGIODYNAMICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ANGIODYNAMICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 20
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
359
-0.74%
|
$2,872
$8.74 P/Share
|
|
Jul 20
2023
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-3.06%
|
$4,928
$8.74 P/Share
|
|
Jul 20
2023
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
333
-0.57%
|
$2,664
$8.74 P/Share
|
|
Jul 20
2023
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
332
-1.15%
|
$2,656
$8.74 P/Share
|
|
Jul 20
2023
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,982
-0.56%
|
$23,856
$8.74 P/Share
|
|
Jul 20
2023
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
717
-0.62%
|
$5,736
$8.74 P/Share
|
|
Jul 19
2023
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,159
-2.56%
|
$25,272
$8.92 P/Share
|
|
Jul 19
2023
|
Stephen A Trowbridge EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,769
+6.64%
|
-
|
|
Jul 19
2023
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
1,230
-2.0%
|
$9,840
$8.92 P/Share
|
|
Jul 19
2023
|
Scott Centea SVP/GM, VIT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,415
+5.26%
|
-
|
|
Jul 19
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
1,404
-2.73%
|
$11,232
$8.92 P/Share
|
|
Jul 19
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Exercise of conversion of derivative security
|
Direct |
3,900
+7.05%
|
-
|
|
Jul 19
2023
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,575
-4.82%
|
$12,600
$8.92 P/Share
|
|
Jul 19
2023
|
Dave Helsel SVP Global Operations and R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
4,371
+11.8%
|
-
|
|
Jul 19
2023
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,379
-2.03%
|
$91,032
$8.92 P/Share
|
|
Jul 19
2023
|
James C Clemmer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,572
+5.33%
|
-
|
|
Jul 19
2023
|
Karen A Licitra |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+24.6%
|
-
|
|
Jul 19
2023
|
Michael E Tarnoff |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+27.4%
|
-
|
|
Jul 19
2023
|
Eileen O'Shea Auen |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+20.4%
|
-
|
|
Jul 19
2023
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+20.32%
|
-
|
|
Jul 19
2023
|
Howard W Donnelly |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+11.68%
|
-
|
|
Jul 19
2023
|
Wesley Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+13.93%
|
-
|
|
Jul 19
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Grant, award, or other acquisition
|
Direct |
11,384
+19.09%
|
-
|
|
Jul 19
2023
|
Dennis S Meteny |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+10.85%
|
-
|
|
Jul 19
2023
|
James C Clemmer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
92,181
+14.69%
|
-
|
|
Jul 19
2023
|
Scott Centea SVP/GM, VIT |
BUY
Grant, award, or other acquisition
|
Direct |
10,588
+15.28%
|
-
|
|
Jul 19
2023
|
Dave Helsel SVP Global Operations and R&D |
BUY
Grant, award, or other acquisition
|
Direct |
10,789
+27.13%
|
-
|
|
Jul 19
2023
|
Stephen A Trowbridge EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
28,691
+19.83%
|
-
|
|
Jul 19
2023
|
Laura Piccinini SVP International |
BUY
Grant, award, or other acquisition
|
Direct |
14,168
+41.32%
|
-
|
|
Jul 19
2023
|
Lorinda Burgess |
BUY
Grant, award, or other acquisition
|
Direct |
17,041
+50.0%
|
-
|
|
Jul 17
2023
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
313
-1.69%
|
$2,817
$9.56 P/Share
|
|
Jul 17
2023
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
351
-0.72%
|
$3,159
$9.56 P/Share
|
|
Jul 17
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
279
-0.75%
|
$2,511
$9.56 P/Share
|
|
Jul 17
2023
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,262
-0.51%
|
$20,358
$9.56 P/Share
|
|
Jul 17
2023
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
376
-0.43%
|
$3,384
$9.56 P/Share
|
|
Jul 14
2023
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
679
-3.54%
|
$6,111
$9.63 P/Share
|
|
Jul 14
2023
|
Scott Centea SVP/GM, VIT |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-1.06%
|
$4,653
$9.63 P/Share
|
|
Jul 14
2023
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
596
-1.58%
|
$5,364
$9.63 P/Share
|
|
Jul 14
2023
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,906
-1.09%
|
$44,154
$9.63 P/Share
|
|
Jul 14
2023
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,362
-1.53%
|
$12,258
$9.63 P/Share
|
|
Jun 01
2023
|
Laura Piccinini SVP International |
SELL
Payment of exercise price or tax liability
|
Direct |
1,400
-19.04%
|
$12,600
$9.64 P/Share
|
|
Feb 03
2023
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
555
-0.62%
|
$7,215
$13.43 P/Share
|
|
Feb 01
2023
|
Richard C Rosenzweig SVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,137
-6.74%
|
$14,781
$13.36 P/Share
|
|
Jan 31
2023
|
Dave Helsel SVP Global Operations and R&D |
SELL
Open market or private sale
|
Direct |
4,633
-19.45%
|
$55,596
$12.95 P/Share
|
|
Oct 12
2022
|
Stephen A Trowbridge EVP and CFO |
BUY
Open market or private purchase
|
Direct |
1,083
+1.19%
|
$14,079
$13.82 P/Share
|
|
Oct 10
2022
|
James C Clemmer President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+2.17%
|
$150,000
$15.0 P/Share
|
|
Jul 29
2022
|
Dave Helsel SVP Global Operations and R&D |
SELL
Open market or private sale
|
Direct |
5,000
-17.35%
|
$110,000
$22.44 P/Share
|
|
Jul 20
2022
|
James C Clemmer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
33,094
+6.99%
|
-
|
|
Jul 20
2022
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Grant, award, or other acquisition
|
Direct |
3,987
+9.55%
|
-
|
|
Jul 20
2022
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
3,426
+7.96%
|
-
|